(2026) Genotype-phenotype correlations and cancer risk in monogenic epidermodysplasia verruciformis. Journal of the European Academy of Dermatology and Venereology : JEADV. e755-e758. ISSN 1468-3083 (Electronic) 0926-9959 (Print) 0926-9959 (Linking)
Full text not available from this repository.
Official URL: https://www.ncbi.nlm.nih.gov/pubmed/41609194
| Item Type: | Article |
|---|---|
| Keywords: | epidermodysplasia verruciformis inborn errors of immunity monogenic disorder persistent human papillomavirus infection persistent warts Novartis, BMS, Janssen, Boehringer Ingelheim, and has received research grants from Almirall, Prometheus Biosciences, Janssen, Eli Lilly, Boehringer Ingelheim and Galderma. Hakon Hakonarson, together with the Children's Hospital of Philadelphia, is an equity holder in Nobias Therapeutics, which is developing MEK inhibitor therapy for complex lymphatic anomalies. Jean-Laurent Casanova serves on the scientific advisory boards of ADMA Biologics Inc., Kymera Therapeutics and Elixiron Immunotherapeutics. Sajjad Biglari, Leila Youssefian, Atefeh Sohanforooshan Moghaddam, Roya Sherkat, Fatemeh Vahidnezhad, Amir Hossein Saeidian, Mahdi Akbarzadeh, Vivien Beziat, Emmanuelle Jouanguy and Hassan Vahidnezhad have no conflicts of interest to declare. |
| Page Range: | e755-e758 |
| Journal or Publication Title: | Journal of the European Academy of Dermatology and Venereology : JEADV |
| Journal Index: | Pubmed |
| Volume: | 40 |
| Number: | 9 |
| Identification Number: | https://doi.org/10.1111/jdv.70315 |
| ISSN: | 1468-3083 (Electronic) 0926-9959 (Print) 0926-9959 (Linking) |
| Depositing User: | خانم ناهید ضیائی |
| URI: | http://eprints.mui.ac.ir/id/eprint/34669 |
Actions (login required)
 |
View Item |